Selentus develops innovative haemostatic technologies for better surgical outcomes. Selentus is developing a pipeline of products based on its unique technology platform that offer high performance, low cost manufacture and avoid the use of blood-derived materials. Selentus' lead product, TenaTac®, was approved for sale in Europe in September 2019.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Biocity, Nottingham,nottinghamshire Ng31 6sf,united Kingdom
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- selentus.com
- Keywords
- Haemostats and Tissue adhesion.
- HQ
- Nottingham, Nottinghamshire
Selentus Science Limited Questions
Selentus Science Limited's website is selentus.com
Selentus Science Limited's LinkedIn profile is https://uk.linkedin.com/company/selentus
Selentus Science Limited has
6 employees.
View email and phone details for 6
employees at Selentus Science Limited.
Selentus Science Limited's industry is
Medical Equipment Manufacturing
Selentus Science Limited's top competitors are
Pipeline Organics,
Neobe Therapeutics,
3io Therapeutics,
Amferia Kills Bacteria,
Pedratech,
Biostone Biologics,
Intelligent Omics Ltd,
Telenostic,
Thermology Health (A Spinout From The National Physical Laboratory),
Alveron Pharma.
Selentus Science Limited's categories are Medical Equipment Manufacturing
Selentus Science Limited's founding year is 2016
